Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection

ClinicalTrials.gov ID: NCT03597347

Public ClinicalTrials.gov record NCT03597347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Non-controlled, Multicenter, Pilot Trial, Using Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial (NTM) Infection

Study identification

NCT ID
NCT03597347
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Savara Inc.
Industry
Enrollment
14 participants

Conditions and interventions

Interventions

  • Molgramostim nebulizer solution Drug
  • PARI eFlow nebulizer system Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2019
Primary completion
Oct 1, 2020
Completion
Oct 1, 2020
Last update posted
Jan 9, 2023

2019 – 2020

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
National Jewish Health Denver Colorado 80206
Central Florida Pulmonary Group Orlando Florida 32803
Northwell Health New Hyde Park New York 11042
University of North Carolina at Chapel Hill - UNC Marisco Clinical Research Center Chapel Hill North Carolina 27517
UT Southwestern Medical Center Dallas Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03597347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 9, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03597347 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →